LOPINAVIR for Maternal exposure timing unspecified: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where LOPINAVIR was used for Maternal exposure timing unspecified.
Most Reported Side Effects for LOPINAVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 244 | 19.7% | 73 | 44 |
| Exposure during pregnancy | 184 | 14.8% | 22 | 26 |
| Virologic failure | 170 | 13.7% | 7 | 3 |
| Drug resistance | 134 | 10.8% | 9 | 3 |
| Off label use | 133 | 10.7% | 41 | 70 |
| Lipodystrophy acquired | 126 | 10.1% | 1 | 1 |
| Premature baby | 107 | 8.6% | 28 | 13 |
| Diplopia | 89 | 7.2% | 0 | 4 |
| Treatment failure | 89 | 7.2% | 1 | 1 |
| Premature delivery | 88 | 7.1% | 1 | 5 |
| Eyelid ptosis | 87 | 7.0% | 0 | 0 |
| Mitochondrial toxicity | 82 | 6.6% | 0 | 0 |
| Viral mutation identified | 76 | 6.1% | 0 | 0 |
| Progressive external ophthalmoplegia | 73 | 5.9% | 0 | 0 |
| Pathogen resistance | 54 | 4.4% | 0 | 3 |
Other Indications for LOPINAVIR
Hiv infection (706)
Covid-19 (108)
Prophylaxis against hiv infection (96)
Product used for unknown indication (68)
Antiretroviral therapy (47)
Antiviral treatment (34)
Foetal exposure during pregnancy (16)
Hepatitis viral (10)
Perinatal hiv infection (10)
Covid-19 pneumonia (9)
Other Drugs Used for Maternal exposure timing unspecified
VALPROATE (1,477)
ADALIMUMAB (1,280)
NATALIZUMAB (492)
RITONAVIR (486)
EMTRICITABINE\TENOFOVIR DISOPROXIL (333)
LOPINAVIR\RITONAVIR (278)
DIVALPROEX (254)
INTERFERON BETA-1A (245)
DIMETHYL (212)
ATAZANAVIR (169)